Shilpa Medicare informs about outcome of board meeting

27 Dec 2016 Evaluate

Shilpa Medicare has informed that the Board of Directors, at their meeting held on December 26, 2016, allotted 3,025,000, equity share of Re 1 each at a premium of Rs 569 per share in the name of TA FII Investors, IFS Court, Bank Street, Twenty Eight, Cybercity Ebene 72201, Mauritius pursuant to the resolution passed by the shareholders at their Extra-Ordinary General Meeting held on 26th December, 2016 and in-principal approvals received from BSE (Dt:8th December, 2016) National Stock Exchange of India (Dt.23rd December, 2016). The Company has further intimate that Naresh Patwari has been co-opted as an Additional (non-executive and non-independent) Director of the Company, being the nominee of TA FII Investors with effect from this date, subject to regularization by shareholders at the ensuing annual general meeting of the Company in accordance with the requirements of the Companies Act, 2013.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

331.30 -2.65 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×